Antibodies to bufalin prevent inhibition of Na/K ATPase and...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S141100, C424S130100

Reexamination Certificate

active

08062639

ABSTRACT:
The present invention relates to compositions and methods of use thereof for treatment of clinical conditions manifested from and/or exacerbated by a decrease or an inhibition of Na/K ATPase activity. The invention relates to composition comprises monoclonal or polyclonal antibodies to bufalin and/or bufalin sulfate, or vaccination against bufalin and/or bufalin sulfate, which prevents or attenuates inhibition of Na/K ATPase activity thereby attenuating the adverse physiological effects of bufalin and/or bufalin sulfate inhibition. The invention also relates to methods of treating hemorrhagic, septic shock, cardiogenic shock, shock resulting from physical trauma, diabetes, mental depression, bipolar disorder and schizophrenia comprising administering a therapeutically effective amount of an bufalin monoclonal or polyclonal antibody.

REFERENCES:
patent: 2006/0134106 (2006-06-01), Adair

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies to bufalin prevent inhibition of Na/K ATPase and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to bufalin prevent inhibition of Na/K ATPase and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to bufalin prevent inhibition of Na/K ATPase and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4284436

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.